Alexander Schuth
Fundador en DENALI THERAPEUTICS INC. .
Fortuna: 9 M $ al 30/04/2024
Cargos activos de Alexander Schuth
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
DENALI THERAPEUTICS INC. | Director de Operaciones | 01/03/2015 | - |
Director Financiero/CFO | 01/05/2022 | - | |
Fundador | 14/10/2013 | - | |
Secretario Corporativo | 01/06/2015 | - | |
Molecular Health GmbH
Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Director/Miembro de la Junta | - | - |
Historial de carrera de Alexander Schuth
Antiguos cargos conocidos de Alexander Schuth.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/08/2005 | 01/03/2015 |
Merrill Lynch International
Merrill Lynch International Investment Banks/BrokersFinance Merrill Lynch International (MLI-UK) is a brokerage firm headquartered in London, UK. The firm was founded in 1988 and is a subsidiary of ML UK Capital Holdings Ltd., ultimately owned by Bank of America Corp. (NYSE: BAC) in the US. MLI-UK provides brokerage services to individual and retail clients. | Corporate Officer/Principal | 01/01/2001 | 01/05/2003 |
Posbelduf Biotech AG
Posbelduf Biotech AG Pharmaceuticals: MajorHealth Technology Molecular Health AG provides clinico-molecular informatic solutions. The firm’s approach allows doctors translate patient-specific molecular and genomic data, clinical history, and published scientific evidence into drug choices. The company was founded by Friedrich von Bohlen in 2004 and is headquartered in Basel, Switzerland. | Director/Miembro de la Junta | - | - |
Fundador | - | - |
Formación de Alexander Schuth.
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Charité - Universitätsmedizin Berlin | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 4 |
Alemania | 3 |
Suiza | 2 |
Operativa
Director/Board Member | 2 |
Founder | 2 |
Corporate Officer/Principal | 2 |
Sectorial
Health Technology | 4 |
Consumer Services | 3 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
DENALI THERAPEUTICS INC. | Health Technology |
Empresas privadas | 4 |
---|---|
Posbelduf Biotech AG
Posbelduf Biotech AG Pharmaceuticals: MajorHealth Technology Molecular Health AG provides clinico-molecular informatic solutions. The firm’s approach allows doctors translate patient-specific molecular and genomic data, clinical history, and published scientific evidence into drug choices. The company was founded by Friedrich von Bohlen in 2004 and is headquartered in Basel, Switzerland. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Merrill Lynch International
Merrill Lynch International Investment Banks/BrokersFinance Merrill Lynch International (MLI-UK) is a brokerage firm headquartered in London, UK. The firm was founded in 1988 and is a subsidiary of ML UK Capital Holdings Ltd., ultimately owned by Bank of America Corp. (NYSE: BAC) in the US. MLI-UK provides brokerage services to individual and retail clients. | Finance |
Molecular Health GmbH
Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Commercial Services |
- Bolsa de valores
- Insiders
- Alexander Schuth
- Experiencia